Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for Laura Goff

5 Open Trials

    Trial Type Protocol No. &
    Open Date
    Summary

    Treatment

    VICCGI17112

    03/21/2018

    A Phase 1/2 Study of Olaparib in Combination with Ramucirumab in Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

    Treatment

    VICCGI1754

    11/22/2017

    A Pivotal Trial of ARQ 087 in Subjects with FGFR2 Gene Fusion Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma

    Treatment

    VICCGI16149

    11/10/2017

    An Open-Label Multicenter Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Subjects with Advanced Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma

    Treatment

    VICCGI1721

    06/23/2017

    A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of AG-120 in Previously-Treated Subjects with Nonresectable or Metastatic Cholangiocarcinoma with an IDH1 Mutation

    Treatment

    VICCGI1655

    12/14/2016

    A Randomized, Multicenter, Double Blind, Phase III Study of Nivolumab or Placebo in Subjects with Resected Lower Esophageal, or Gastroesophageal Junction Cancer


    Print this page for your doctor